Épisodes

  • 27: Risk Revolution Bookshelf: What We’re Reading (And Why It Matters)

    27: Risk Revolution Bookshelf: What We’re Reading (And Why It Matters)
    Aug 28 2025
    In this special Book Club edition of Risk Revolution, join Nuala, Lori & Val as they dive into three powerful books that are reshaping the way we think about leadership, culture, and decision-making in regulated industries.

    From David Marquet’s Turn the Ship Around to Amy Edmondson’s The Right Kind of Wrong and Vesper & McFarland's Quality Risk Management: A Practical Guide,
    the risk revolutionaries explore how trust, psychological safety, and letting go of outdated habits all contribute to better quality, stronger teams, and smarter risk-based decisions.

    Expect honesty, personal reflections, and a few surprises along the way.

    Links:
    A Google Talk featuring L. David Marquet on his insights from the book - https://www.youtube.com/watch?v=IzJL8zX3EVk&t=247s
    A YouTube Video featuring Amy Edmonson: https://www.youtube.com/watch?v=C2zFnHCWWfw
    Voir plus Voir moins
    1 h et 1 min
  • 26: The 2025 Half-Time Huddle

    26: The 2025 Half-Time Huddle
    Jul 31 2025
    Nuala and Val look back at the previous episodes this year to highlight some of the most interesting interviews, topics, and revelations. Nuala and Val share key insights from Professor Kevin O'Donnell, Anders Vinther, Matt Pearson, Barry Byrne, and Rosanna Bules.

    The Fearless Organisation and The Right Kind of Wrong by Amy Edmonson,
    Turn the Ship Around by David Marquet.
    Quality Risk Management: A Practical Guide by Jim Vesper & Amanda McFarland.
    Voir plus Voir moins
    42 min
  • 25: In an AI-powered pharma world, where does Knowledge Management really belong?

    25: In an AI-powered pharma world, where does Knowledge Management really belong?
    Jun 30 2025
    Val is back from the Knowledge Summit — energized, inspired, and asking the big question:
    In an AI-powered pharma world, where does Knowledge Management really belong?
    Is it Quality, L&D, Tech Ops… or somewhere in between?
    Tune in as the team unpacks where KM delivers the most value — and why it matters more than ever.

    This week's show notes:

    • Integrating Knowledge Management into QMS for Early Stage Companies: A Practical Approach for Improved Business Performance and Growth, Part 1
      • https://www.bioprocessintl.com/regulatory-affairs/integrating-knowledge-management-into-qms-for-early-stage-companies-a-practical-approach-for-improved-business-performance-and-growth-part-1
    • Integrating Knowledge Management into QMS for Early Stage Companies: A Practical Approach for Improved Business Performance and Growth, Part 2
      • https://www.bioprocessintl.com/regulatory-affairs/integrating-knowledge-management-into-qms-for-early-stage-companies-a-practical-approach-for-improved-business-performance-and-growth-part-2
    • Knowledge as the Currency of Managing Risk: A Novel Framework to Unite Quality Risk Management and Knowledge Management by Marty Lipa, Kevin O'Donnell & Anne Greene
      • https://prst.ie/wp-content/uploads/2020/11/Knowledge-as-the-Currency-of-Managing-Risk-Uniting-QRM-and-KM-28Oct20-FINAL-for-Level3.pdf
    Voir plus Voir moins
    41 min
  • 24: Decoding GMP Supplier Oversight by Applying QRM with Confidence

    24: Decoding GMP Supplier Oversight by Applying QRM with Confidence
    May 29 2025
    In this episode, we're decoding what effective GMP supplier oversight really looks like—and how sponsors can apply Quality Risk Management (QRM) principles to build smarter, more sustainable programs. We will cover supplier oversight, ongoing performance monitoring, and risk-based decision-making, with practical insights and a focus on what matters most: protecting product quality and patient safety.
    Whether you’re building a supplier oversight program from the ground up or refining what’s already in place, this episode delivers the tools and mindset shifts sponsors need to lead with intention and compliance.

    This month's guest is Rosanna Bules, a Certified Quality Auditor. Rosanna is a strategic and results-driven Quality Assurance Leader with 17+ years of biopharmaceutical experience (commercial and clinical), specializing in GMP Supplier Quality Management (SQM), audits, regulatory compliance, and risk-based quality oversight. Expertise in developing risk-based programs, conducting domestic and international audits, establishing and negotiating quality technical agreements (QTAs), and fostering cross-functional collaboration to ensure compliance with global regulations/guidelines. Proven track record in designing/developing processes, improving/streamlining existing processes, leading teams, and delivering measurable improvements in supplier oversight and management.

    This month’s show notes include:
    • Link to Integrating Knowledge Management into QMS for Early Stage Companies: A Practical Approach for Improved Business Performance and Growth, Part 1
    • Link to Integrating Knowledge Management into QMS for Early Stage Companies: A Practical Approach for Improved Business Performance and Growth, Part 2
    • Link to FDA Chapter 56 Drug Quality Assurance: Outsourcing Facility Inspections
    • Link to Guidelines of 19 March 2015 on the formalised risk assessment for ascertaining the appropriate good manufacturing practice for excipients of medicinal products for human use
    • Link to FDA Guidance for Industry: Contract Manufacturing Arrangements for Drugs: Quality Agreements
    Voir plus Voir moins
    56 min
  • 23: From Battlefields to Biopharma: Knowledge Management in High-Risk Worlds

    23: From Battlefields to Biopharma: Knowledge Management in High-Risk Worlds
    Apr 30 2025
    In this compelling Risk Revolution episode, Valerie Mulholland chats with Barry Byrne, Head of Knowledge Management Strategy at Novartis and a former Irish military officer. Barry shares his journey from Lebanon’s conflict zones to global pharma, revealing how real-time knowledge sharing can save lives, not just on the battlefield but also in medicine. They explore the transformative power of AI, storytelling, and sense-making in regulated environments, and what pharma can learn from NASA, the military, and consulting giants—a must-listen for leaders driving cultural and knowledge change in high-stakes industries.


    This month’s show notes include:

    • Links to the knowledge summit https://www.knowledgesummitdublin.com/
    • Links to David Snowdon’s Cynefin website https://thecynefin.co/
    • The Work of the PRST – Marty Lipa & Paige Kaine https://prst.ie/
    • TED TALK by the author of Turn the Ship Around, David Marquet https://www.youtube.com/watch?v=HYXH2XUfhfo
    • BOOK: Turn the Ship around: Turn the Ship Around!: A True Story of Turning Followers into Leaders by David Marquet (Author), Stephen R. Covey (Foreword – 7 habits of Highly Effective People)
    • BOOK: A Lifecycle Approach to Knowledge Excellence in the Biopharmaceutical Industry (Biotechnology and Bioprocessing by Nuala Calnan, Marty Lipa, Paige Kane and Jose Menezes
    • BOOK: The Checklist Manifesto by Atul Gawande
    • What is Leadership: with David Marquet
    • David Marquet, Former-Captain, US Navy Seals: Turn The Ship Around!
    Voir plus Voir moins
    1 h et 3 min
  • 22: Role of Culture and Behaviors in Leading Hi-Performing Teams and Delivering Enhanced Performance

    22: Role of Culture and Behaviors in Leading Hi-Performing Teams and Delivering Enhanced Performance
    Mar 31 2025
    In this episode, Nuala Calnan chats with Matt Pearson, VP of Quality System & Risk Management at Guardant Health, about how to “switch on” your organisation to proactively manage risk and continuously improve your processes by focusing on creating a culture, where mindsets, behaviors and employee engagement deliver real performance improvement for the business. Matt explains his views on achieving a quality culture, how to strive for workplace engagement, how an organization's structure can lead to fractures, and the three critical enablers for anyone planning to implement sustainable culture change within their organization.


    SHOW NOTES:
    1. ISPE Cultural Excellence Report (2017) https://guidance-docs.ispe.org/doi/book/10.1002/9781946964618
    2. Carol Dweck Mindset book: https://www.amazon.com/Mindset-Psychology-Carol-S-Dweck/dp/0345472322
    3. Access Shane Craddock’s materials: https://shanecradock.com/
    Voir plus Voir moins
    1 h et 1 min
  • 18: Quality Business Leadership

    18: Quality Business Leadership
    Feb 26 2025
    This month on Risk Revolution, Lori Richter chats with Anders Vinther, PhD, the Founder & CEO of Quality Business Administration (QBA). Lori and Anders discuss sustained product quality, consistent product supply, and robust financial performance. Anders shares the Six Traits of a QBL. Anders also shares his thoughts on preserving quality as a company value and the role of engagement in delivering this competitive business advantage.

    This month’s show notes include:

    Learn more about the QBA program: https://qbaleaders.com/

    QBA program feedback from participants: https://qbaleaders.com/qbl-program-feedback/

    Want to apply to be in a cohort? https://qbaleaders.com/certification-program-application-form/

    Taking a Stand for Pharmaceutical Quality: The Rise of the Quality Business Leader

    Deming Institute: https://deming.org/the-deming-philosophy/
    Voir plus Voir moins
    54 min
  • 18: Happy Birthday QRM!

    18: Happy Birthday QRM!
    Jan 31 2025
    The Risk Revolution Crew is back with an exciting celebratory podcast. Join Nuala, Val, and Lori as they reflect on 20 years of QRM with Prof Kevin O’Donnell. This week’s guest needs almost no introduction to our listeners as he was the rapporteur for the ICH Q9(R1) update, chairs the PIC/s expert circle on QRM and is the Market Compliance Manager with the Irish Regulatory Agency the HPRA. Prof O’Donnell shares his reflections on the QRM journey and what is to come.

    Listeners should note that Prof O’Donnell’s views are his own and do not necessarily reflect those of the agencies and organizations referenced above.

    Show Notes

    ICH Q9(R1) and the supporting training materials can be accessed here:

    https://www.ich.org/page/quality-guidelines

    The EMA recommendations draw on lessons learned from the presence of nitrosamines in sartan medicines

    https://www.ema.europa.eu/en/news/european-regulators-make-recommendations-drawing-lessons-learnt-presence-nitrosamines-sartan-medicines

    Technical Report No. TR 68 (Revised 2024): Risk-Based Approach for Prevention and Management of Drug Shortages

    https://www.pda.org/bookstore/product-detail/7852-technical-report-no-68

    Voir plus Voir moins
    44 min